Myelodysplastic Syndrome
📧 Sign up to get email alerts when something new happens for Myelodysplastic Syndrome.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2019-10-21Clinical Trial Update: Management of Platelet Transfusion Therapy in Patients With Blood Cancer or Treatment-Induced Thrombocytopenia [Phase 2]
Phase 2 clinical trial assessing management of platelet transfusion therapy in patients with blood cancers or treatment-induced thrombocytop…
-
CLINICAL_TRIALS trial_result · 2019-10-11Clinical Trial Update: Donor Umbilical Cord Blood Transplant in Treating Patients With Hematologic Cancer [Phase 2]
Phase 2 clinical trial update on donor umbilical cord blood transplant for hematologic cancers; status completed with results posted.
-
CLINICAL_TRIALS trial_result · 2019-09-19Clinical Trial Update: A Dose Escalation Phase I Study to Assess the Safety and Clinical Activity of Multiple Cancer Indications [Phase 1, Phase 2]
A dose-escalation Phase I study is evaluating safety and preliminary activity of a multi-indication cancer therapy in acute myeloid leukemia…
-
CLINICAL_TRIALS trial_result · 2019-09-06Clinical Trial Update: WEE1 Inhibitor AZD1775 With or Without Cytarabine in Treating Patients With Advanced Acute Myeloid Leukemia or Myelodysplastic Syndrome [Phase 2]
Phase 2 trial evaluating the WEE1 inhibitor AZD1775 with or without cytarabine in advanced acute myeloid leukemia or myelodysplastic syndrom…
-
CLINICAL_TRIALS trial_result · 2019-07-11Clinical Trial Update: Study With Azacitidine in Pediatric Subjects With Newly Diagnosed Advanced Myelodysplastic Syndrome (MDS) and Juvenile Myelomonocytic Leukemia (JMML) [Phase 2]
A Phase 2 clinical trial evaluating azacitidine in pediatric patients with newly diagnosed advanced myelodysplastic syndrome and juvenile my…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2019-06-26Clinical Trial Update: Filgrastim, Cladribine, Cytarabine, and Mitoxantrone Hydrochloride in Treating Patients With Newly Diagnosed or Relapsed/Refractory Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndromes [Phase 1, Phase 2]
Phase 1/2 trial evaluating a combination including filgrastim, cladribine, cytarabine, and mitoxantrone in newly diagnosed or relapsed/refra…
-
CLINICAL_TRIALS trial_result · 2019-05-14Clinical Trial Update: Safety, Clinical Activity, Pharmacokinetics (PK) and Pharmacodynamics Study of GSK2879552, Alone or With Azacitidine, in Subjects With High Risk Myelodysplastic Syndromes (MDS) [Phase 1, Phase 2]
Phase 1/2 trial evaluating GSK2879552 alone or with azacitidine in high-risk myelodysplastic syndromes; study terminated with results posted…
-
CLINICAL_TRIALS trial_result · 2019-05-01Clinical Trial Update: Safety and Efficacy of BL-8040 for the Mobilization of Donor Hematopoietic Stem Cells and Allogeneic Transplantation in Patients With Advanced Hematological Malignancies [Phase 2]
Phase 2 clinical trial evaluating BL-8040 for mobilizing donor hematopoietic stem cells to enable allogeneic transplantation in patients wit…
-
CLINICAL_TRIALS trial_result · 2019-04-23Clinical Trial Update: Pilot Study of Leuprolide to Improve Immune Function After Allogeneic Bone Marrow Transplantation [Phase 2]
Phase 2 pilot trial evaluating leuprolide to enhance immune function after allogeneic bone marrow transplantation has completed and results …
-
CLINICAL_TRIALS trial_result · 2019-04-23Clinical Trial Update: DT388IL3 Fusion Protein in Treating Patients With Acute Myeloid Leukemia or Myelodysplastic Syndromes [Phase 1, Phase 2]
Clinical trial update for DT388IL3 fusion protein in acute myeloid leukemia and myelodysplastic syndromes (Phase 1/2) completed with results…
-
CLINICAL_TRIALS trial_result · 2019-03-20Clinical Trial Update: Study of US-ATG-F to Prevent Chronic Graft Versus Host Disease (GVHD) [Phase 3]
A Phase 3 trial evaluating US-ATG-F to prevent chronic graft-versus-host disease in hematologic malignancy patients has completed with resul…
-
CLINICAL_TRIALS trial_result · 2019-03-05Clinical Trial Update: A Study of E6201 for the Treatment of Advanced Hematologic Malignancies With FLT3 and/or Ras Mutations [Phase 1, Phase 2]
Clinical trial update for E6201 in advanced hematologic malignancies with FLT3 and/or Ras mutations (Phase 1/2) shows terminated status; res…
-
CLINICAL_TRIALS trial_result · 2019-02-26Clinical Trial Update: Pilot Study Evaluating Safety & Efficacy of DCBT: NiCord® & UNM CBU to Patients With Hematological Malignancies [Phase 1, Phase 2]
A pilot Phase 1/2 study evaluating safety and efficacy of NiCord and UNM CBU in patients with various hematologic malignancies has completed…
-
CLINICAL_TRIALS trial_result · 2019-02-21Clinical Trial Update: CAMELLIA: Anti-CD47 Antibody Therapy in Haematological Malignancies [Phase 1]
This update reports the completion of a Phase 1 study of CAMELLIA, an anti-CD47 antibody therapy, in hematologic malignancies.
-
CLINICAL_TRIALS trial_result · 2019-01-28Clinical Trial Update: Treatment of Elderly Patients With Acute Myeloid Leukemia (AML) and High Risk Myelodysplastic (MD) Syndrome With Laromustine and Infusional Cytarabine [Phase 1, Phase 2]
This trial update covers a Phase 1/Phase 2 study of laromustine combined with infusional cytarabine in elderly patients with acute myeloid l…
-
CLINICAL_TRIALS trial_result · 2019-01-28Clinical Trial Update: Cohort Study of New Prognostic Factors With Peripheral Blood and Bone Marrow Evaluation at the Time of Diagnosis and Relapse in Myelodysplastic Syndrome
This clinical trial update describes a cohort study evaluating new prognostic factors using peripheral blood and bone marrow at diagnosis an…
-
CLINICAL_TRIALS trial_result · 2019-01-25Clinical Trial Update: Yttrium-90 Anti-CD45 Monoclonal Antibody BC8 Followed by Donor Stem Cell Transplant in Treating Patients With High-Risk AML, ALL, or MDS [Phase 1]
Phase 1 clinical trial evaluating Yttrium-90 anti-CD45 monoclonal antibody BC8 followed by donor stem cell transplant in patients with high-…
-
CLINICAL_TRIALS trial_result · 2019-01-18Clinical Trial Update: Inducible Regulatory T Cells (iTregs) in Non-Myeloablative Sibling Donor Peripheral Blood Stem Cell Transplantation [Phase 1]
Phase 1 trial evaluating inducible regulatory T cells (iTregs) in non-myeloablative sibling donor peripheral blood stem cell transplantation…
-
CLINICAL_TRIALS trial_result · 2018-12-31Clinical Trial Update: Donor Stem Cell Transplant With No or Low-Intensity Chemotherapy Using Sirolimus and Treated Immune Cells to Treat Blood and Lymph Cancers [Phase 2]
Phase 2 trial evaluating donor stem cell transplantation with sirolimus and treated immune cells, for blood and lymph cancers, terminated wi…
-
CLINICAL_TRIALS trial_result · 2018-12-28Clinical Trial Update: Vosaroxin for Intermediate 2 or High-risk MDS After Failure With Hypomethylating Agent-based Therapy [Phase 1, Phase 2]
Phase 1/2 clinical trial evaluating Vosaroxin in adults with intermediate-2 or high-risk myelodysplastic syndrome after failure of hypomethy…
-
CLINICAL_TRIALS trial_result · 2018-12-06Clinical Trial Update: A Phase II Trial of SGI-110 in Patients With IPSS High and Int 2 Myelodysplastic Syndrome, Acute Myeloid Leukemia With 20-30% Marrow Blasts or Chronic Myelomonocytic Leukemia Type 2 Not Responding to Azacitidine or Decitabine After at Least 6 Courses or Relapsing After a Response [Phase 2]
Phase II trial evaluating SGI-110 in patients with various high-risk myelodysplastic syndromes and related conditions not responding to prio…
-
CLINICAL_TRIALS trial_result · 2018-11-15Clinical Trial Update: Decitabine and Clofarabine in Higher Risk Myelodysplastic Syndromes (MDS) [Phase 2]
Phase 2 trial update studying decitabine and clofarabine in higher risk myelodysplastic syndromes has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2018-11-08Clinical Trial Update: GVHD Prophylaxis With Post Transplant Cyclophosphamide for Patients With Renal Insufficiency Undergoing a Conventional 8/8 HLA-matched Related or Unrelated Donor Allogeneic Hematopoietic Stem Cell Transplant [NA]
Clinical trial update on GVHD prophylaxis with post-transplant cyclophosphamide in patients with renal insufficiency receiving matched relat…
-
CLINICAL_TRIALS trial_result · 2018-11-07Clinical Trial Update: Clofarabine Plus Cytarabine in Patients With Previously Untreated Acute Myeloid Leukemia and High-risk Myelodysplastic Syndrome [Phase 2]
Phase 2 trial evaluating clofarabine plus cytarabine in previously untreated acute myeloid leukemia and high-risk myelodysplastic syndrome h…
-
CLINICAL_TRIALS trial_result · 2018-11-01Clinical Trial Update: Effect of Deferiprone on Oxidative-Stress and Iron-Overload in Low Risk Transfusion-Dependent MDS Patients [Phase 2]
Phase 2 trial assessing deferiprone for oxidative stress and iron overload in low-risk transfusion-dependent myelodysplastic syndrome patien…